Reunion Neuroscience Inc. Gains 39.42%

Wed, Jan 04, 2023 at 07:00 PM

Reunion Neuroscience Inc. (REUN:NASDAQ) jumped higher at $1.45, a gain of 39.4%. On Wed, Jan 04, 2023, REUN:NASDAQ hit a New 2-Week High of $1.45. The stock got featured on our News Catalysts scanner on Wed, Jan 04, 2023 at 08:14 AM in the 'INVESTOR UPDATE' category. From Wed, Dec 21, 2022, the stock recorded 50.00% Up Days and 55.56% Green Days

About Reunion Neuroscience Inc. (REUN:NASDAQ)

Field Trip is a global leader in the development and delivery of psychedelic therapies.

Top 10 Gainers:

Vivos Therapeutics Inc. (VVOS:NASDAQ), 154.05%
Cryptyde Inc. (TYDE:NASDAQ), 81.35%
VYNE Therapeutics Inc. (VYNE:NASDAQ), 70.05%
Shift Technologies Inc. (SFT:NASDAQ), 57.5%
Relativity Acquisition Corp. (RACY:NASDAQ), 47.65%
eFFECTOR Therapeutics Inc. (EFTR:NASDAQ), 44.9%
Elys Game Technology Corp. (ELYS:NASDAQ), 39.96%
Reunion Neuroscience Inc. (REUN:NASDAQ), 39.42%
ASLAN Pharmaceuticals Limited (ASLN:NASDAQ), 37.72%
Theseus Pharmaceuticals Inc. (THRX:NASDAQ), 36.28%